Search Abstracts Program


Session 60   Poster Presentations
Primary HIV/SIV Infection
Tuesday 1:30 - 3:30 pm
Hall A
502Antiretroviral Resistance Among Patients with Primary HIV Infection in the Southeastern U.S.-Impact on Treatment Outcome
C. Hicks*1, J. Eron2, J. Lennox3, C. Pilcher2, S. Fiscus2, A. Weintrob1, J. Giner1, P. Menezes2, E. Patrick3, T. Alcorn4
1Duke Univ Med Ctr, Durham, NC; 2Univ of North Carolina, Chapel Hill; 3Emory Univ, Atlanta, GA; and 4LabCorp, Inc, Research Triangle Park, NC
503Replication Characteristics of Drug-resistant and Drug-susceptible HIV-1 Variants Isolated during Primary Infection
V. Simon*1, N. Padte1, J. Vanderhoeven1, D. Murray1, M. Di Mascio2, M. Markowitz1
1Aaron Diamond AIDS Res Ctr, Rockefeller Univ, New York, NY and 2Los Alamos Natl Lab, NM
504Frequency of Transmitted Drug Resistance and Identification of Phylogenetic Clusters in a Homogenous Cohort of Newly Infected Individuals
V. Simon*1, C. Hogan1, M. Louie1, S. Vasan1, L. Rowe1, A. Hurley1, N. Padte1, J. Vanderhoeven1, K. Dawson2, P. Balfe 1, M. Markowitz 1
1Aaron Diamond AIDS Res Ctr, Rockefeller Univ, New York, NY and 2ViroLogic, San Francisco, CA
505The Relative Transmissibility of Drug Resistant HIV-1 among Couples
R. M. Grant*1,2, R. Atchison1, K .Franses2, A .Rollins2, M .Warmerdam1, J. O. Kahn2, F. M. Hecht2
1Gladstone Inst of Virology and Immunology, San Francisco, CA and 2Univ of California at San Francisco
506Pre-Exisiting HIV-specific CD8+ CTL Fail to Prevent HIV Infection in an HIV Sero-discordant Couple
S. Fidler*1, S. Pinheiro2, C. Nicholson1, T. Dong2, H-T. Zhang3, J. Clarke1, R. Phillips3, S. Rowland-Jones2, J. Weber1
1Imperial Coll, London, UK; 2Inst of Molecular Med, Oxford, UK; and 3Dunn Sch, Univ of Oxford, UK
507Evaluation of HLA Class II DRB1 and DQB1 Genotypes in Discordant Zambian Couples at Risk of Heterosexual HIV-1 Transmission
J. Tanga*1, A. Penman-Aguilar1, E. Lobashevsky1, I. Zulu2, S. Allen1, G. Aldrovandi1, R. A. Kaslow1
1Univ of Alabama, Birmingham and 2Univ of Zambia, Lusaka
508Virus Load in HIV-1 Seroconverters Who Share HLA Class I and Class II Alleles with Their Respective Transmitting Partners
J. Tang*1, S. Tang1, E. Lobashevsky1, I. Zulu2, G. Aldrovandi1, S. Allen1, R. A. Kaslow1
1Univ of Alabama at Birmingham and 2Univ of Zambia, Lusaka
509Defining the 'Viral Setpoint' in HIV-1 Infection
S. D. W. Frost*1, S. Holte2, L. Wang2, E. S. Daar3, D. D. Richman1,4, S. J. Little1
1Univ of California at San Diego; 2Fred Hutchinson Cancer Res Ctr, Seattle, WA; 3Harbor-Univ of California, Los Angeles; and 4Veterans Admin Med Ctr, La Jolla, CA
510Influence of HLA-B57 on Clinical Presentation and Viral Control during Acute HIV-1 Infection
M. Altfeld*1, M. M. Addo1, E. S. Rosenberg1, F. M. Hecht2, P. K. Lee1, M. Vogel3, R. Draenert1, X. G. Yu1, M. N. Johnston1, Todd M. Allen1, Rafick P. Sekaly4, Jay A. Levy5, Jürgen K. Rockstroh3, Philip J. R. Goulder1, Bruce D. Walker1
1Massachusetts General Hosp, Boston; 2Univ of California at San Francisco; 3Univ of Bonn, Germany; 4Inst de Recherches Cliniques de Montreal, Canada; and 5Univ of California at San Francisco
511The Role of Target Cells and Specific Immunity in Primary SIV Infection
R. R. Regoes*1, R. Antia1, D. Garber2, G. Silvestri2, M. B. Feinberg1,2, S. I. Staprans1,2
1Emory Univ, Atlanta GA and 2Emory Vaccine Res Ctr, Atlanta GA